The technical field of this disclosure is personal medical systems, particularly, personal medical devices and methods of use with restricted mode challenge.
Advances in electronics have resulted in the miniaturization of medical devices such that medical devices which previously required large stationary equipment can now be worn about the person, who can be monitored or receive treatment while pursuing normal daily tasks.
One area of such advances has been in the treatment of diabetes. An estimated twenty-six million people in the United States, or about 8% of the population, have diabetes. This percentage is expected to increase in the near-term as the population ages. Wearable glucose monitors and insulin pumps have been developed which allow persons under treatment for diabetes to be monitored and receive insulin while carrying on their day-to-day tasks.
Unfortunately, advances in insulin delivery to improve treatment can also create new problems when the user enters a restricted mode to program the insulin delivery, such as basal or bolus infusions. One problem arises when a user becomes overly familiar with the programming procedure and resorts to a series of memorized keystrokes: the user presses keys without monitoring the visual display of the insulin pump to confirm that they are programming the insulin pump as they desire. Such behavior can arise when the user is shy about displaying the insulin pump in public where it can draw attention. Another problem arises when inadvertent contact with the insulin pump controls results in unintended delivery, suspension, or resumption of insulin administration. Yet another problem arises when a user attempts to program the insulin pump from memory, even though the visual display is inoperable and no longer displays user input parameters.
It would be desirable to have a personal medical device and method of use with restricted mode challenge that would overcome the above disadvantages.
One aspect of the invention provides a personal medical device for employment by a user and having a restricted mode, the medical device including: a memory operable to store programming code; a processor operably connected to the memory; a user input operably connected to the processor and having input buttons to receive input from the user; and a user display operably connected to the processor to display output to the user. The processor is responsive to the programming code to: detect a user request for entry to the restricted mode; display a user input image on the user display in response to the detected user request, the user input image including display buttons corresponding to the input buttons; highlight one of the display buttons; detect actuation of one of the input buttons on the user input; and deny entry to the restricted mode when the one of the input buttons does not correspond to the highlighted one of the display buttons.
Another aspect of the invention provides a personal medical system for providing a therapeutic fluid to a user, the personal medical system including: a reservoir containing the therapeutic fluid; a personal medical device having a restricted mode, the personal medical device being operably connected to the reservoir to receive the therapeutic fluid; and an infusion set operably connected to the personal medical device to receive the therapeutic fluid. The personal medical device further includes a memory operable to store programming code; a processor operably connected to the memory; a user input operably connected to the processor and having input buttons to receive input from the user; a user display operably connected to the processor to display output to the user; and a fluid driver in fluid communication between the reservoir and the infusion set, the fluid driver being responsive to a flow control signal from the processor to drive the therapeutic fluid from the reservoir to the user through the infusion set. The processor is responsive to the programming code to: detect a user request for entry to the restricted mode; display a user input image on the user display in response to the detected user request, the user input image including display buttons corresponding to the input buttons; highlight one of the display buttons; detect actuation of one of the input buttons on the user input; and deny entry to the restricted mode when the one of the input buttons does not correspond to the highlighted one of the display buttons.
Yet another aspect of the invention provides a method of use for a personal medical device having a user display and a user input, the user input having a plurality of input buttons, the method including detecting a user request for entry to a restricted mode of the personal medical device; displaying a user input image on the user display in response to the detected user request, the user input image including display buttons corresponding to the input buttons; highlighting one of the display buttons; detecting actuation of one of the input buttons on the user input; and denying entry to the restricted mode when the one of the input buttons does not correspond to the highlighted one of the display buttons.
The foregoing and other features and advantages of the invention will become further apparent from the following detailed description of the presently preferred embodiments, read in conjunction with the accompanying drawings. The detailed description and drawings are merely illustrative of the invention, rather than limiting the scope of the invention being defined by the appended claims and equivalents thereof.
The personal medical device 120 for employment by the user and having a restricted mode includes a memory 122 operable to store programming code; a processor 124 operably connected to the memory 122; a user input 126 operably connected to the processor 124 and having input buttons to receive input from the user; a user display 128 operably connected to the processor 124 to display output to the user; and a fluid driver 130 in fluid communication between the reservoir 110 and the infusion set 140, the fluid driver 130 being responsive to a flow control signal from the processor 124 to drive the therapeutic fluid from the reservoir 110 to the user through the infusion set 140.
The personal medical device 120 is prevented from entering a restricted mode, such as a mode in which the user can set or alter the therapy to be or being administered, without confirming that the user identifies a highlighted display button on the user display 128. A restricted mode is defined herein as any operational mode of the personal medical device 120 providing information or control to which restriction of access is desired: information about the user, information about therapy being administered to the user, and/or control of therapy being administered to the user. Exemplary restricted modes include the basal selection mode in which basal injection therapy can be selected and/or adjusted, and the bolus selection mode in which bolus injection therapy can be selected and/or adjusted. The processor 124 is responsive to the programming code stored in the memory 122 to detect a user request to request entry to the restricted mode; display a user input image on the user display 128 in response to the detected user request, the user input image including display buttons corresponding to the input buttons; highlight one of the display buttons; detect actuation of a second one of the input buttons on the user input 126; and deny entry to the restricted mode when the second one of the input buttons does not correspond to the highlighted one of the display buttons. The processor 124 can also be responsive to the programming code to permit entry to the restricted mode when the second one of the input buttons corresponds to the highlighted one of the display buttons. In one embodiment, the user request is actuation of an input button on the user input 126. In another embodiment, the user request is voice actuation such as when voice recognition is employed.
The processor 124 can also be operable to highlight the one of the display buttons as desired for a particular application. In one embodiment, the highlighting includes randomly highlighting the one of the display buttons. In another embodiment, the highlighting can follow a newly generated random sequence. For example, the newly generated random sequence of highlighted display buttons on subsequent challenge screens can be A, B, D, C with each letter corresponding to one of the display buttons and the user can key in the sequence of highlighted display buttons A, B, D, C to enter the restricted mode. This embodiment can be used by a care giver such a parent where the end user is not capable of making therapy decisions.
The personal medical device 120 can be any personal medical device for which presentation of a challenge screen before entry to a restricted mode is desired. In the particular example of
The processor 124 of the personal medical device 120 can be any processor desired for a particular application. Exemplary processors include a central processing unit and a microprocessor. The processor can include or be attached to auxiliary equipment, such as memory, data storage, additional processors, input/output devices, antennas, and the like, as required to perform various functions.
The user input 126 can include any type of input buttons desired for a particular application. In one embodiment, the input buttons can be electromechanical. In another embodiment, the user input 126 can be a touch-sensitive screen and the input buttons represented graphically on the touch-sensitive screen.
The user display 128 can be any type of display desired for a particular application, such as an LED display, an OLED display, an LCD display, or the like. In one embodiment, the user display 128 is a touch-sensitive display, with the user input 126 and the user display 128 included in the single touch-sensitive display. The input buttons of the user input 126 can be touch-sensitive buttons aligned with the display buttons of the user display 128 corresponding to the input buttons, so that the highlighted display button in the user input image appears on the same spot on the user display 128 as the corresponding input button.
The flow path for the therapeutic fluid is from the reservoir 110, through the driver 130, and through the infusion set 140 to the user. The reservoir 110 can be separate from, integral to, or replaceable within the housing of the personal medical device 120. In one embodiment, the reservoir 110 is a sealed vial replaceable within the personal medical device 120. In another embodiment, the reservoir 110 is refillable. The fluid driver 130 can be any type of pump operable to move the therapeutic fluid as desired for a particular application. The infusion set 140 can employ a cannula subcutaneously inserted in the user to deliver the therapeutic fluid. Those skilled in the art will appreciate that the fluidic connections illustrated are exemplary and that other configurations are equally possible, e.g., in other examples the infusion set 100 can be connected directly to the reservoir 110.
The user sensor 150 can be any sensor providing a sensed physiological signal from the user to the personal medical device 120. When the personal medical device 120 is an insulin pump, the user sensor 150 can be a glucose monitor. In one example, the user sensor 150 is a continuous glucose monitor. The user sensor 150 can be operably connected to the processor 124 by wire or wirelessly.
Referring to
In this embodiment, the user display 250 displays a home screen 251 having a status bar 252, a sensed glucose graph 254, a numerical display 256, a first mode selection indication 258 (e.g., Bolus selection mode), and a second mode selection indication 260 (e.g., Basal selection mode). The status bar 252 can display information regarding the personal medical device 200, such as battery charge status, reservoir level, audio mode (audio and/or vibrate), and the like as desired for a particular application, and can be selectable to open a sub-menu. The status bar sub-menu can optionally be a restricted mode, presenting a challenge screen before access to the sub-menu is allowed. The sensed glucose graph 254 can display sensed glucose level versus time when a user sensor providing a sensed physiological signal, such as a glucose sensor, is used with the personal medical device 200. The numerical display 256 can display numerical and graphical information regarding physiological parameters and therapy being administered. The first mode selection indication 258 (e.g., Bolus selection mode) or the second mode selection indication 260 (e.g. Basal selection mode) can be highlighted to indicate the mode which will be entered when the user actuates the select button 218
The personal medical device 200 also includes a memory (not shown) operable to store programming code and a processor (not shown) operably connected to the memory. The user input 210 and the user display 250 are operably connected to the processor. The processor is responsive to the programming code to detect a user request to request entry to the restricted mode (a user request such as actuation of an input buttons on the user input 210, voice actuation, or the like); display a user input 210 image on the user display 250 in response to the detected user request, the user input 210 image including display buttons corresponding to the input buttons; highlight one of the display buttons; detect actuation of one of the input buttons on the user input 210; and deny entry to the restricted mode when the one of the input buttons does not correspond to the highlighted one of the display buttons. The processor can also be responsive to the programming code to permit entry to the restricted mode when the one of the input buttons corresponds to the highlighted one of the display buttons.
Referring to
Those skilled in the art will appreciate that restricted modes can be selected as desired for a particular application, so that a challenge screen can be displayed to require that the user actuate an input button corresponding to a highlighted display button before the desired screen is displayed. Exemplary restricted modes include the basal selection mode in which basal injection therapy can be selected and/or adjusted, and the bolus selection mode in which bolus injection therapy can be selected and/or adjusted. In one example, menu select can be a restricted mode, i.e., when the user actuates the menu button 214, a challenge screen can be presented in the user display 250.
In another example, wake-from-sleep can be a restricted mode, i.e., when the user display 250 returns from a blank-display sleep mode to an active mode in response to actuation of an input button by the user, the user display 250 can present a challenge screen before any information is displayed. In yet another example, wake-from-sleep can be omitted as a restricted mode when the user had completed a challenge screen permitting entry to another restricted mode when the personal medical device went to sleep. In yet another example, wake-from-sleep can be omitted as a restricted mode and the user can be routed to the home screen to monitor status. In yet another example, specialized display can be a restricted mode, e.g., when the user actuates the select button 218 to display a large sensed glucose graph or detailed status, a challenge screen can be presented in the user display 250 before the specialized display is presented.
In another example, device-on can be a restricted mode, i.e., when the user turns on the personal medical device 200, the user display 250 can present a challenge screen which must be successfully completed by actuating an input button corresponding to a highlighted display button before the user can proceed to any other screen, such as the main menu screen, a screen providing information, a screen allowing user input or control, or the like. The user is denied entry past the challenge screen when the personal medical device 200 is initially turned on unless the challenge screen is successfully completed. In yet another example, device-on can be a restricted mode, but a screen providing information without allowing user input, such as a large sensed glucose graph or the like, can be displayed after the challenge screen has been displayed on the user display 250 for a predetermined time (challenge screen timeout), the user actuates an input button not corresponding to the highlighted display button (user fails challenge screen), the user actuates another button on the personal medical device 200 such as the back button or menu button (user selection), or the like.
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
The highlighting one of the display buttons 630 can be performed as desired for a particular application. In one embodiment, the highlighting one of the display buttons 630 includes randomly highlighting the one of the display buttons. In another embodiment, the highlighting one of the display buttons 630 can follow a newly generated random sequence. For example, the newly generated random sequence of highlighted display buttons on subsequent challenge screens can be A, B, D, C with each letter corresponding to one of the display buttons and the user can key in the sequence of highlighted display buttons A, B, D, C to enter the restricted mode. This embodiment can be used by a care giver such a parent where the end user is not capable of making therapy decisions.
Referring to
Referring to
Referring to
Referring to
Referring to
It is important to note that
While the embodiments of the invention disclosed herein are presently considered to be preferred, various changes and modifications can be made without departing from the spirit and scope of the invention. The scope of the invention is indicated in the appended claims, and all changes that come within the meaning and range of equivalents are intended to be embraced therein.
Number | Name | Date | Kind |
---|---|---|---|
4755173 | Konopka et al. | Jul 1988 | A |
5391250 | Cheney, II et al. | Feb 1995 | A |
5485408 | Blomquist | Jan 1996 | A |
5522803 | Teissen-Simony | Jun 1996 | A |
5665065 | Colman et al. | Sep 1997 | A |
5800420 | Gross et al. | Sep 1998 | A |
5807375 | Gross et al. | Sep 1998 | A |
5925021 | Castellano et al. | Jul 1999 | A |
5954643 | Van Antwerp et al. | Sep 1999 | A |
6017328 | Fischell et al. | Jan 2000 | A |
6049328 | Vanderheiden | Apr 2000 | A |
6186982 | Gross et al. | Feb 2001 | B1 |
6246992 | Brown | Jun 2001 | B1 |
6248067 | Causey, III et al. | Jun 2001 | B1 |
6248093 | Moberg | Jun 2001 | B1 |
6355021 | Nielsen et al. | Mar 2002 | B1 |
6379301 | Worthington et al. | Apr 2002 | B1 |
6544212 | Galley et al. | Apr 2003 | B2 |
6558351 | Steil et al. | May 2003 | B1 |
6591876 | Safabash | Jul 2003 | B2 |
6641533 | Causey, III et al. | Nov 2003 | B2 |
6736797 | Larsen et al. | May 2004 | B1 |
6749587 | Flaherty | Jun 2004 | B2 |
6766183 | Walsh et al. | Jul 2004 | B2 |
6801420 | Talbot et al. | Oct 2004 | B2 |
6804544 | Van Antwerp et al. | Oct 2004 | B2 |
7003336 | Holker et al. | Feb 2006 | B2 |
7029444 | Shin et al. | Apr 2006 | B2 |
7066909 | Peter et al. | Jun 2006 | B1 |
7137964 | Flaherty | Nov 2006 | B2 |
7303549 | Flaherty et al. | Dec 2007 | B2 |
7399277 | Saidara et al. | Jul 2008 | B2 |
7442186 | Blomquist | Oct 2008 | B2 |
7602310 | Mann et al. | Oct 2009 | B2 |
7647237 | Malave et al. | Jan 2010 | B2 |
7699807 | Faust et al. | Apr 2010 | B2 |
7727148 | Talbot et al. | Jun 2010 | B2 |
7785313 | Mastrototaro | Aug 2010 | B2 |
7806886 | Kanderian, Jr. et al. | Oct 2010 | B2 |
7819843 | Mann et al. | Oct 2010 | B2 |
7828764 | Moberg et al. | Nov 2010 | B2 |
7879010 | Hunn et al. | Feb 2011 | B2 |
7890295 | Shin et al. | Feb 2011 | B2 |
7892206 | Moberg et al. | Feb 2011 | B2 |
7892748 | Norrild et al. | Feb 2011 | B2 |
7901394 | Ireland et al. | Mar 2011 | B2 |
7942844 | Moberg et al. | May 2011 | B2 |
7946985 | Mastrototaro et al. | May 2011 | B2 |
7955305 | Moberg et al. | Jun 2011 | B2 |
7963954 | Kavazov | Jun 2011 | B2 |
7977112 | Burke et al. | Jul 2011 | B2 |
7979259 | Brown | Jul 2011 | B2 |
7985330 | Wang et al. | Jul 2011 | B2 |
7990251 | Ford, Jr. | Aug 2011 | B1 |
8024201 | Brown | Sep 2011 | B2 |
8100852 | Moberg et al. | Jan 2012 | B2 |
8114268 | Wang et al. | Feb 2012 | B2 |
8114269 | Cooper et al. | Feb 2012 | B2 |
8137314 | Mounce et al. | Mar 2012 | B2 |
8181849 | Bazargan et al. | May 2012 | B2 |
8182462 | Istoc et al. | May 2012 | B2 |
8192395 | Estes et al. | Jun 2012 | B2 |
8195265 | Goode, Jr. et al. | Jun 2012 | B2 |
8202250 | Stutz, Jr. | Jun 2012 | B2 |
8207859 | Enegren et al. | Jun 2012 | B2 |
8226615 | Bikovsky | Jul 2012 | B2 |
8257259 | Brauker et al. | Sep 2012 | B2 |
8267921 | Yodfat et al. | Sep 2012 | B2 |
8275437 | Brauker et al. | Sep 2012 | B2 |
8277415 | Mounce et al. | Oct 2012 | B2 |
8292849 | Bobroff et al. | Oct 2012 | B2 |
8298172 | Nielsen et al. | Oct 2012 | B2 |
8303572 | Adair et al. | Nov 2012 | B2 |
8305580 | Aasmul | Nov 2012 | B2 |
8308679 | Hanson et al. | Nov 2012 | B2 |
8313433 | Cohen et al. | Nov 2012 | B2 |
8318443 | Norrild et al. | Nov 2012 | B2 |
8323250 | Chong et al. | Dec 2012 | B2 |
8343092 | Rush et al. | Jan 2013 | B2 |
8352011 | Van Antwerp et al. | Jan 2013 | B2 |
8353829 | Say et al. | Jan 2013 | B2 |
20070123819 | Mernoe et al. | May 2007 | A1 |
20100160861 | Causey, III et al. | Jun 2010 | A1 |
20100198142 | Sloan | Aug 2010 | A1 |
20140325065 | Birtwhistle | Oct 2014 | A1 |
20150025498 | Estes | Jan 2015 | A1 |
Number | Date | Country | |
---|---|---|---|
20170106139 A1 | Apr 2017 | US |